Genscript Biotech Corp (1548)

Hong Kong
Currency in HKD
11.24
+0.54(+5.05%)
Delayed Data
1548 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
10.5411.36
52 wk Range
7.4318.00
Key Statistics
Edit
Bid/Ask
11.22 / 11.24
Prev. Close
10.7
Open
10.62
Day's Range
10.54-11.36
52 wk Range
7.43-18
Volume
14.91M
Average Volume (3m)
12.39M
1-Year Change
-20.15%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1548 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
22.74
Upside
+102.34%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Genscript Biotech Corp Company Profile

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People’s Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy. The Life Science Services and Products segment provides products and services in various categories, including DNA synthesis, plasmid DNA preparation, molecular cloning, oligonucleotide synthesis, protein and antibody expression and purification, peptide synthesis, antibody development, IVT RNA production, assay cell line development and vector packing, molecular diagnostics tools, and genome editing tools and reagents, as well as instrument for protein analysis and purification, cell isolation and activation. The Biologics Development Services segment offers end-to-end service offerings to biologics development and manufacturing for biopharma and biotech partners, as well as therapeutic antibodies, and gene/cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment constructs non-pathogenic microbial strains; and develops and produces industrial enzymes. The Cell Therapy segment discovers and develops chimeric antigen receptor CAR-T cell therapies for the treatment of liquid and solid tumors. It has a strategic partnership with Multiply Labs for automation of the cell isolation phase of cell therapy manufacturing, reducing the complexity of this laborious process. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the People’s Republic of China.

Compare 1548 to Peers and Sector

Metrics to compare
1548
Peers
Sector
Relationship
P/E Ratio
−16.6x−3.6x−0.6x
PEG Ratio
−3.620.010.00
Price/Book
2.4x2.5x2.6x
Price / LTM Sales
2.9x3.5x3.1x
Upside (Analyst Target)
110.7%104.2%52.8%
Fair Value Upside
Unlock15.6%8.4%Unlock

Analyst Ratings

11 Buy
0 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 22.74
(+102.34% Upside)

Earnings

Latest Release
Mar 21, 2022
EPS / Forecast
-0.96 / --
Revenue / Forecast
-- / 2.07B
EPS Revisions
Last 90 days

FAQ

What Is the Genscript Biotech Corp (1548) Stock Price Today?

The Genscript Biotech Corp stock price today is 11.24.

What Stock Exchange Does Genscript Biotech Corp Trade On?

Genscript Biotech Corp is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for Genscript Biotech Corp?

The stock symbol for Genscript Biotech Corp is "1548."

What Is the Genscript Biotech Corp Market Cap?

As of today, Genscript Biotech Corp market cap is 24.04B.

What is Genscript Biotech Corp Earnings Per Share?

The Genscript Biotech Corp EPS is -0.084.

From a Technical Analysis Perspective, Is 1548 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.